LIVE MARKET TRACKER :   BSE SENSEX        |    NSE NIFTY    
GLOBAL MARKETS :  NASDAQ      |    FSI London      |    NIKKEI Japan  
  USD GBP EUR CAD AUD INR
USD -
GBP -
EUR -
CAD -
AUD -
INR -
Indian-Commodity  :  Corporate  :  Glenmark Pharmaceuticals presents Phase 2a data on GBR 830

Glenmark Pharmaceuticals presents Phase 2a data on GBR 830 (18-May-2018)

Glenmark Pharmaceuticals has presented new data from a Phase 2a, proof-of-concept study of GBR 830, an investigational, anti-OX40 monoclonal antibody being studied for the treatment of moderate-to-severe atopic dermatitis (AD), that were presented at the International Investigative Dermatology Meeting (IID) in Orlando, Florida. The exploratory Phase 2a study was conducted to investigate the safety of GBR 830, evaluate its effects on AD biomarkers, and generate the first clinical evidence of its biological activity.

Patients were randomized to receive two doses of GBR 830 or placebo, and were assessed for response at Day 29 and Day 71. New data from the study demonstrated that subsequent to treatment with GBR 830, epidermal hyperplasia, proliferation, and mRNA biomarkers for disease activity were reduced, indicating a possible effect on both the acute and chronic stages of AD.

Glenmark Pharmaceuticals is a global pharmaceutical company. The company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs). Its segments are India, United States, Latin America, Europe and Rest of the World (ROW).


Top News Today
LTI get nod to close its wholly owned subsidiary
(25-May-2018)

LTI get nod to close its wholly owned subsidiaryLarsen & Toubro Infotech (LTI) has received an approval for the closure of its wholly owned subsidiary i.e. Larsen & Toubro Infotech Austria GmbH (LTI Austria). The Board of Directors of......click on news to read complete article.

Cox & Kings' arm gets NBFC license form RBI
(25-May-2018)

Cox & KingsCox & Kings' wholly owned subsidiary - Cox & Kings Financial Service has received a Non-Banking Finance Company (NBFC) license from Reserve Bank of India (RBI).Cox & Kings Financial......click on news to read complete article.

Triveni Engineering to incorporate wholly owned subsidiary
(25-May-2018)

Triveni Engineering to incorporate wholly owned subsidiaryTriveni Engineering & Industries has received an approval to incorporate wholly owned subsidiary as a Special Purpose Vehicle (SPV) for implementation of a project/order for about Rs 438 crore......click on news to read complete article.

International Stock News
US markets end lower on Thursday
(25-May-2018)

US markets end lower on ThursdayThe US markets ended in red terrain on Thursday, as geopolitical worries hovered over markets after Trump called off the summit that was set to take place June 12 in Singapore. The cancellation followed......click on news to read complete article.

Asian markets exhibit mixed trend in early deals on Thursday
(24-May-2018)

Asian markets exhibit mixed trend in early deals on ThursdayAsian market indices are exhibiting a mixed trend in early deals on Thursday after US stocks reversed early losses and finished higher as investors appraised the Federal Reserve's signal that it is not......click on news to read complete article.

US markets end higher as Fed hints at gradual rate hikes
(24-May-2018)

US markets end higher as Fed hints at gradual rate hikesThe US markets ended higher on Wednesday after the minutes from the Federal Reserve's May 2 meeting confirmed that policy makers support a June rate increase and are maintaining a calm attitude about the......click on news to read complete article.

 

     
  
Recent Corporate News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.